5,7-Dichloro-2-methyl-1H-imidazo[4,5-b]pyridine, 97.0%, 1g

Methyl 3-bromoindole-6-carboxylate, 95.0%, 1g

1-ethyl-6-(propan-2-yl)-1H-indole-2-carboxylic acid, 95.0%, 2g

1-(3-Fluoro-2-nitrophenyl)piperidin-4-amine hydrochloride, 95.0%, 1g

4-((4-Fluorophenyl)amino)-4-oxobutanoic acid, 95+%, 250mg

1-Hexyl-3-methyl-imidazolium chloride, min. 98%, 100 g, glass packaging

Trimethyl 1,2,4-Cyclohexanetricarboxylate (cis- and trans- mixture)>97.0%(GC)1g

1,4-DIOXASPIRO[4.5]DECANE-8-ACETONITRILE, 95.0%, 5g

4-(Chloromethyl)benzoic Acid>98.0%(GC)(T)25g

3-amino-N-cyclohexyl-2-methylbenzamide, 95.0%, 1g

(R)-tert-Butyl (1-(piperidin-4-yl)ethyl)carbamate, 98%, 250mg

(2-Aminophenyl)-N-(2-morpholin-4-ylphenyl)formamide, 95.0%, 10g

(5-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methanol, 95.0%, 1g